Glucosamine Enhances Body Weight Gain and Reduces Insulin Response in Mice Fed Chow Diet but Mitigates Obesity, Insulin Resistance and Impaired Glucose Tolerance in Mice High-Fat Diet

被引:19
|
作者
Hwang, Ji-Sun [1 ]
Park, Ji-Won [2 ]
Nam, Moon-Suk [3 ]
Cho, Hyeongjin [4 ]
Han, Inn-Oc [1 ]
机构
[1] Inha Univ, Coll Med, Dept Physiol & Biophys, Inchon 400712, South Korea
[2] Inha Univ, Dept Life Sci, Inchon 400712, South Korea
[3] Inha Univ, Coll Med, Dept Endocrinol & Metab Clin Pharmacol, Inchon 400712, South Korea
[4] Inha Univ, Dept Chem, Inchon 400712, South Korea
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2015年 / 64卷 / 03期
关键词
Glucosamine; Obesity; Insulin resistance; ACTIVATED PROTEIN-KINASE; IN-VIVO; SKELETAL-MUSCLE; ACID OXIDATION; RAT; HEXOSAMINES; LIVER; INFLAMMATION; PATHWAY; AMIDOTRANSFERASE;
D O I
10.1016/j.metabol.2014.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. This study investigated the potential of glucosamine (GlcN) to affect body weight gain and insulin sensitivity in mice normal and at risk for developing diabetes. Methods. Male C57BL/6 J mice were fed either chow diet (CD) or a high fat diet (HFD) and the half of mice from CD and HFD provided with a solution of 10% (w/v) GlcN. Total cholesterol and nonesterified free fatty acid levels were determined. Glucose tolerance test and insulin tolerance test were performed. HepG2 human hepatoma cells or differentiated 3 T3-L1 adipocytes were stimulated with insulin under normal (5 mM) or high glucose (25 mM) conditions. Effect of GlcN on 2-deoxyglucose (2-DG) uptake was determined. JNK and Akt phosphorylation and nucleocytoplasmic protein O-GlcNAcylation were assayed by Western blotting. Results. GlcN administration stimulated body weight gain (6.58 +/- 0.82 g vs. 11.1 +/- 0.42 g), increased white adipose tissue fat mass (percentage of bodyweight, 3.7 +/- 0.32 g vs. 5.61 +/- 0.34 g), and impaired the insulin response in livers of mice fed CD. However, GlcN treatment in mice fed HFD led to reduction of body weight gain (18.02 +/- 0.66 g vs. 16.22 +/- 0.96 g) and liver weight (2.27 +/- 0.1 vs. 1.85 +/- 0.12 g). Furthermore, obesity-induced insulin resistance and impaired Akt insulin signaling in the liver were alleviated by GlcN administration. GlcN inhibited the insulin response under low (5 mM) glucose conditions, whereas it restored the insulin response for Akt phosphorylation under high (25 mM) glucose conditions in HepG2 and 3 T3-L1 cells. Uptake of 2-DG increased upon GlcN treatment under 5 mM glucose compared to control, whereas insulin-stimulated 2-DG uptake decreased under 5 mM and increased under 25 mM glucose in differentiated 3 T3-L1 cells. Conclusion. Our results show that GlcN increased body weight gain and reduced the insulin response for glucose maintenance when fed to normal CD mice, whereas it alleviated body weight gain and insulin resistance in HFD mice. Therefore, the current data support the integrative function of the HBP reflecting the nutrient status of lipids or glucose and further implicate the importance of the pathway in insulin signaling for the regulation of metabolism. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:368 / 379
页数:12
相关论文
共 50 条
  • [21] Lactate supplementation mitigates obesity in high-fat diet-fed mice
    Vrzackova, N.
    Svoboda, P.
    Trnovska, J.
    Haluzik, M.
    Ruml, T.
    Zelenka, J.
    FEBS OPEN BIO, 2021, 11 : 490 - 490
  • [22] Obesity induced insulin resistance and oxidative stress in mice fed a high fat diet
    Mells, Jamie E.
    Gletsu-Miller, Nana
    Lin, Edward
    Hansen, Jason M.
    FASEB JOURNAL, 2007, 21 (05): : A112 - A112
  • [23] The Mechanisms by Which Adiponectin Reverses Insulin Resistance in High-Fat Diet Fed Mice
    Li, Xiruo
    Zhang, Dongyan
    Perry, Rachel J.
    Vatner, Daniel F.
    Goedeke, Leigh
    Zhang, Ye
    Shulman, Gerald I.
    DIABETES, 2019, 68
  • [24] Whey Protein Reduces Early Life Weight Gain in Mice Fed a High-Fat Diet
    Tranberg, Britt
    Hellgren, Lars I.
    Lykkesfeldt, Jens
    Sejrsen, Kristen
    Jeamet, Aymeric
    Rune, Ida
    Ellekilde, Merete
    Nielsen, Dennis S.
    Hansen, Axel Kornerup
    PLOS ONE, 2013, 8 (08):
  • [25] Mice deficient in glucagon gene exhibit impaired glucose tolerance and the resistance to obesity on high-fat diet feeding
    Ozaki, N.
    Takagi, Y.
    Kinoshita, K.
    Seino, Y.
    Oshida, Y.
    Murata, Y.
    Hayashi, Y.
    DIABETOLOGIA, 2013, 56 : S236 - S236
  • [26] Biocellulose reduces body weight gain of rats fed high-fat diet
    Han, D
    Kwon, EK
    Kim, DW
    Kim, YE
    Kim, IH
    FOOD SCIENCE AND BIOTECHNOLOGY, 2006, 15 (01) : 70 - 76
  • [27] Poplar Propolis Ethanolic Extract Reduces Body Weight Gain and Glucose Metabolism Disruption in High-Fat Diet-Fed Mice
    Cardinault, Nicolas
    Tourniaire, Franck
    Astier, Julien
    Couturier, Charlene
    Perrin, Estelle
    Dalifard, Julie
    Seipelt, Eva
    Mounien, Lourdes
    Letullier, Claire
    Bonnet, Lauriane
    Karkeni, Esma
    Delbah, Naima
    George, Stephane
    Landrier, Jean-Francois
    MOLECULAR NUTRITION & FOOD RESEARCH, 2020,
  • [28] Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet
    Shih, Chun-Ching
    Lin, Cheng-Hsiu
    Lin, Wei-Li
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (02) : 134 - 143
  • [29] Early and Chronic Exposure to Penicillin Increases Obesity and Insulin Resistance in High-Fat Diet-Fed Mice
    Noh, Hye Lim
    Suk, Sujin
    Friedline, Randall H.
    Hu, Xiaodi
    Tran, Duy A.
    Tauer, Lauren A.
    Choi, Jungeun
    Ko, Min-Ji
    Kim, Brandon
    Surapaneni, Tanuj
    Blaser, Martin J.
    Kim, Jason K.
    DIABETES, 2019, 68
  • [30] Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice
    Iffiu-Soltesz, Zsuzsa
    Wanecq, Estelle
    Lomba, Almudena
    Portillo, Maria P.
    Pellati, Federica
    Szoko, Eva
    Bour, Sandy
    Woodley, John
    Milagro, Fermin I.
    Alfredo Martinez, J.
    Valet, Philippe
    Carpene, Christian
    PHARMACOLOGICAL RESEARCH, 2010, 61 (04) : 355 - 363